Related Experiment Video

Updated: Jul 18, 2026

Oligopeptide Competition Assay for Phosphorylation Site Determination
09:16

Oligopeptide Competition Assay for Phosphorylation Site Determination

Published on: May 18, 2017

Receptor for activated C kinase 1 (RACK1) and Src regulate the tyrosine phosphorylation and function of the androgen

Sarah Kraus1, Daniel Gioeli, Tomas Vomastek

  • 1Department of Microbiology and Cancer Center, University of Virginia Health System, Charlottesville, Virginia, USA.

Cancer Research
|November 17, 2006
PubMed

Insights

Receptor for activated C kinase 1 (RACK1) impacts prostate cancer progression by modulating androgen receptor (AR) activity. Down-regulating RACK1 inhibits cancer cell growth and enhances AR-driven gene expression.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Signaling

Background:

  • The androgen receptor (AR) plays a crucial role in prostate cancer (PCa) development and progression, even in cases of apparent androgen independence.
  • Growth factor receptor signaling is upregulated in advanced PCa and can sensitize the AR to androgens, highlighting the importance of understanding signaling pathway modulation of AR function.

Purpose of the Study:

  • To investigate the role of the adaptor/scaffolding protein receptor for activated C kinase 1 (RACK1) in modulating androgen receptor (AR) function in prostate cancer.
  • To elucidate the mechanisms by which RACK1 influences AR activity, including its interaction with tyrosine kinases.

Main Methods:

  • Investigated the interaction between RACK1 and the AR using co-immunoprecipitation assays.
  • Assessed the effect of RACK1 modulation on AR tyrosine phosphorylation and interaction with Src tyrosine kinase.
  • Utilized short interfering RNA (siRNA) to down-regulate RACK1 expression in prostate cancer cells.
  • Measured the impact of RACK1 down-regulation on cell growth and prostate-specific antigen (PSA) transcription in the presence of androgens.

Main Results:

  • RACK1 was shown to modulate the tyrosine phosphorylation of the AR and its interaction with the Src tyrosine kinase.
  • Down-regulation of RACK1 using siRNA significantly inhibited the growth of androgen-treated prostate cancer cells.
  • RACK1 down-regulation led to increased prostate-specific antigen (PSA) transcription in androgen-treated prostate cancer cells.

Conclusions:

  • RACK1 acts as a mediator for cross-talk between the AR and other binding partners, such as Src.
  • RACK1 facilitates AR tyrosine phosphorylation and enhances its transcriptional activity, suggesting a key role in prostate cancer progression.
  • Targeting RACK1 may represent a potential therapeutic strategy for prostate cancer by disrupting AR signaling.

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Concept Videos

Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...